Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Bo, Wängberg"'
Autor:
Sinan Karakaya, Lisa Gunnesson, Erik Elias, Paula Martos-Salvo, Mercedes Robledo, Ola Nilsson, Bo Wängberg, Frida Abel, Sven Påhlman, Andreas Muth, Sofie Mohlin
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors. PGLs can further be divided into sympathetic (sPGLs) and head-and-neck (HN-PGLs). There are virtually no treatment options, and no cure, for metastatic PCCs a
Externí odkaz:
https://doaj.org/article/bab3867431174edda96dfadd196f72e5
Autor:
Peter Bou Rahal, Bo Wängberg
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1358-1361 (2021)
Abstract Despite its rarity, the neuroendocrine adenoma of the middle ear (NEAME) is a differential diagnosis of the middle ear disease. We suspect that the NEAME is underdiagnosed and more cases can be detected through education and personal experie
Externí odkaz:
https://doaj.org/article/9dd3d623e9994002a4a03b08c77635da
Autor:
Johan Spetz, Britta Langen, Nils-Petter Rudqvist, Toshima Z. Parris, Emman Shubbar, Johanna Dalmo, Bo Wängberg, Ola Nilsson, Khalil Helou, Eva Forssell-Aronsson
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-11 (2019)
Abstract Background 177Lu-octreotate is used for therapy of somatostatin receptor expressing neuroendocrine tumors with promising results, although complete tumor remission is rarely seen. Previous studies on nude mice bearing the human small intesti
Externí odkaz:
https://doaj.org/article/75cafa6b47d94faf94e9f39cd20a3b40
Autor:
Bo Wängberg, Peter Bou Rahal
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1358-1361 (2021)
Clinical Case Reports
Clinical Case Reports
Despite its rarity, the neuroendocrine adenoma of the middle ear (NEAME) is a differential diagnosis of the middle ear disease. We suspect that the NEAME is underdiagnosed and more cases can be detected through education and personal experience. Trea
Autor:
Sinan Karakaya, Lisa Gunnesson, Erik Elias, Paula Martos Salvo, Mercedes Robledo, Ola Nilsson, Bo Wängberg, Frida Abel, Sven Påhlman, Andreas Muth, Sofie Mohlin
Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors. PGLs can further be divided into sympathetic (sPGLs) and head-and-neck (HN-PGLs). There are virtually no treatment options, and no cure, for metastatic PCCs and PGLs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae887625ee735f020682679945f7ac3c
https://doi.org/10.1101/2022.05.27.493680
https://doi.org/10.1101/2022.05.27.493680
Autor:
Per Olof Janson, S. Jansson, Håkan Ahlman, Erling Ekerhovd, Gun Abrahamsson, Anders Norström, Bo Wängberg
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 99:1297-1302
Introduction Mitotane is an adrenolytic drug that is used as an adjuvant to treat adrenocortical carcinoma. This study aimed to evaluate the clinical course and pathogenetic mechanisms underlying ovarian cyst formation in women of reproductive age di
Autor:
Erik Elias, Johanna Svensson, Anders Bergström, Ola Nilsson, Peter Bernhardt, Viktor Johanson, Ida Marin, Anna-Karin Elf, Bo Wängberg
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2035, p 2035 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2035, p 2035 (2021)
Simple Summary Small intestinal neuroendocrine tumors (SI-NETs) are slow growing tumors expressing somatostatin receptors (SSTR), which are targeted in diagnostic and therapeutic methods. A fairly new treatment that targets SSTR2 is peptide receptor
Autor:
Anna-Karin Elf, Viktor Johanson, Ida Marin, Anders Bergström, Ola Nilsson, Johanna Svensson, Bo Wängberg, Peter Bernhardt, Erik Elias
Purpose Small intestinal neuroendocrine tumours (SI-NET) often present with distant metastases at diagnosis. Peptide receptor radiotherapy (PRRT) with radiolabelled somatostatin analogues is a systemic treatment that increases overall survival (OS) i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::858fe95705652961d00cc42019060ef6
https://doi.org/10.21203/rs.2.21978/v1
https://doi.org/10.21203/rs.2.21978/v1
Autor:
Tobias Åkerström, Joakim Crona, Alberto Delgado Verdugo, Lee F Starker, Kenko Cupisti, Holger S Willenberg, Wolfram T Knoefel, Wolfgang Saeger, Alfred Feller, Julian Ip, Patsy Soon, Martin Anlauf, Pier F Alesina, Kurt W Schmid, Myriam Decaussin, Pierre Levillain, Bo Wängberg, Jean-Louis Peix, Bruce Robinson, Jan Zedenius, Martin Bäckdahl, Stefano Caramuta, K Alexander Iwen, Johan Botling, Peter Stålberg, Jean-Louis Kraimps, Henning Dralle, Per Hellman, Stan Sidhu, Gunnar Westin, Hendrik Lehnert, Martin K Walz, Göran Åkerström, Tobias Carling, Murim Choi, Richard P Lifton, Peyman Björklund
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41926 (2012)
Aldosterone producing lesions are a common cause of hypertension, but genetic alterations for tumorigenesis have been unclear. Recently, either of two recurrent somatic missense mutations (G151R or L168R) was found in the potassium channel KCNJ5 gene
Externí odkaz:
https://doaj.org/article/8e3599de100c4ef9802dce0a7af360fa
Autor:
Christina Swärd, Anna Rehammar, Ola Nilsson, Yvonne Arvidsson, Bo Wängberg, Gülay Altiparmak, Ellinor Andersson, Erik Kristiansson, Anders Bergström
Publikováno v:
Modern Pathology. 31:1302-1317
The aim of this study was to define the miRNA profile of small intestinal neuroendocrine tumors and to search for novel molecular subgroups and prognostic biomarkers. miRNA profiling was conducted on 42 tumors from 37 patients who underwent surgery f